iosi conference-2019 agenda brochure with faculty · immuno-oncology society of india 1st...

6

Upload: others

Post on 13-Aug-2020

1 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: IOSI Conference-2019 Agenda Brochure with faculty · IMMUNO-ONCOLOGY SOCIETY OF INDIA 1st Immuno-Oncology Society of India Congress 2019 15th-17th MARCH, 2019 TATA MEMORIAL CENTRE

Page 2: IOSI Conference-2019 Agenda Brochure with faculty · IMMUNO-ONCOLOGY SOCIETY OF INDIA 1st Immuno-Oncology Society of India Congress 2019 15th-17th MARCH, 2019 TATA MEMORIAL CENTRE

Page 3: IOSI Conference-2019 Agenda Brochure with faculty · IMMUNO-ONCOLOGY SOCIETY OF INDIA 1st Immuno-Oncology Society of India Congress 2019 15th-17th MARCH, 2019 TATA MEMORIAL CENTRE

Page 4: IOSI Conference-2019 Agenda Brochure with faculty · IMMUNO-ONCOLOGY SOCIETY OF INDIA 1st Immuno-Oncology Society of India Congress 2019 15th-17th MARCH, 2019 TATA MEMORIAL CENTRE

Page 5: IOSI Conference-2019 Agenda Brochure with faculty · IMMUNO-ONCOLOGY SOCIETY OF INDIA 1st Immuno-Oncology Society of India Congress 2019 15th-17th MARCH, 2019 TATA MEMORIAL CENTRE

Page 6: IOSI Conference-2019 Agenda Brochure with faculty · IMMUNO-ONCOLOGY SOCIETY OF INDIA 1st Immuno-Oncology Society of India Congress 2019 15th-17th MARCH, 2019 TATA MEMORIAL CENTRE

IMMUNO-ONCOLOGY SPEAKERS BD&L AND INVESTMENT FORUM · 4th annual immuno oncology bd&l and investment forum sachs associates are delighted to welcome you to the: 4th immuno-oncology

United States Oncology/Immuno-Oncology · United States Oncology/Immuno-Oncology ... • Strategic overview of the oncology franchise ... • Oncology-specific market access and field

UNDERSTANDING THE ROLE OF Immuno-OncologyUnderstanding the Role of Immuno-Oncology In Treating Cancer. 4 Immuno-oncology is the study and development of treatments that take advantage

What’s now and next in Immuno-Oncology?...5 What’s now and next in Immuno-Oncology? Having demonstrated comparable efficacy in treating cancer, Immuno-Oncology is being rapidly

Immuno-Oncology and Immunotherapy - IntechOpen · Immuno-Oncology and Immunotherapy R. Cornelissen, J.G.J.V. Aerts and J.P.J.J. Hegmans Erasmus Medical Centre, Rotterdam The Netherlands

Immuno-oncology therapy biomarkers differences …...Immuno-oncology therapy biomarkers differences between polyoma-virus positive and negative Merkel cell carcinomas Zoran Gatalica,

Immuno oncology wp

The Next Era in Immuno-Oncology - Arizona State University COA... · The Next Era in Immuno-Oncology Presentation at Community Oncology Alliance Annual Meeting Orlando, FL April 15,

Generalized Pairwise Comparison on Immuno- Oncology clinical … Oncology... · 2017. 11. 16. · Generalized Pairwise Comparison on Immuno-Oncology clinical trial data: a case study

G. Poste. The Next Era in Immuno-Oncology

Next Gen Immuno-Oncology Congress - MnM … Gen Immuno-Oncology...The Next Gen Immuno-Oncology Congress 2017 took place in London, ... Technology Shire, Austria ... “The topics and

Top 5 Trends Immuno-oncology

Part 3 Immuno-Inflammation, Oncology & Rare Diseases … · Part 3 . Immuno-Inflammation, Oncology & Rare Diseases . Patrick Vallance . Immuno-Inflammation . Okay, thanks very much

Immuno-oncology: an introduc2on

Leerink Partners Immuno-Oncology Roundtable . - Pfizer

Immuno-Oncology Agent Immune-Related Adverse Event ... · Oxford University Hospitals Immuno-oncology agent immune-related adverse event clinical guideline Version 1.0. – April

Immuno-Oncology Therapies to Treat Lung Cancer cancer patient... · Immuno-Oncology Therapies to Treat Lung Cancer ONCHQ14NP07519. Introduction: Immuno-oncology represents an innovative

AT THE FOREFRONT OF IMMUNO-ONCOLOGY

2017 Immuno-Oncology Medicines in Development - PhRMAphrma-docs.phrma.org/files/dmfile/MID_Immuno-Oncology-2017_Drug-List1.pdf · 2017 Immuno-Oncology Medicines in Development Adoptive

Immuno-oncology & Radiotherapy: advances and practical ...brain-mets.com/files/31/presentation_2017/13h40_Moyal.pdf · Immuno-oncology & Radiotherapy: advances and practical issues

Tumor-specific Immuno-Onclogy Small Molecule Oncolytic Immunotherapy · Small Molecule Immunotherapy Immuno-Oncology ... •Clinical-stage, multi-indication viable, immuno-oncology

AT THE FOREFRONT OF IMMUNO-ONCOLOGY...AT THE FOREFRONT OF IMMUNO-ONCOLOGY 3 SCANCELL IS OPERATING AT THE FOREFRONT OF IMMUNO-ONCOLOGY Expected to exceed US$100bn p.a. by 2022 (source:

WHITE PAPER IMMUNO-ONCOLOGY: PAST, PRESENT AND FUTURE

IMMUNO-ONCOLOGY COMBINATION DRUG DEVELOPMENT …PANEL 2: IMMUNO-ONCOLOGY COMBINATION DRUG DEVELOPMENT FOR PATIENTS WITH DISEASE PROGRESSION AFTER INITIAL ANTI-PD-(L)1 THERAPY IMMUNO-ONCOLOGY

Optimize Immuno-oncology Drug Discovery and Development ... · Optimize Immuno-oncology Drug Discovery and ... pathophysiology, and optimized clinical trial design to identify:

Immuno-Oncology And Autoimmune Diseases

White Paper IMMUNO-ONCOLOGY CLINICAL DEVELOPMENT€¦ · White Paper IMMUNO-ONCOLOGY CLINICAL DEVELOPMENT Moving novel therapies forward FORREST ANTHONY, M.D., PH.D., Senior Director

Leerink Partners Immuno-Oncology Roundtable. · Leerink Partners Immuno-Oncology Roundtable. Pfizer Oncology Presentation ... types; similar profile to competitors • Efficiency

BEST OF IMMUNO-ONCOLOGY

Japan Oncology/Immuno-Oncology - PharmaForce International · Japan Oncology/Immuno-Oncology Complete Benchmarking of Leading Oncology Sales and Marketing Organizations: Key Expenditures

Understanding Immuno-Oncology - Benefits Canada Immuno-Oncology. ... ASCO Recommendations to Raise the Bar for Clinical Trials ... diarrhea (27%), rash (26%),

Scientific Report 2017 1. Oncology Institute of Southern ... · IOSI Oncology Institute of Southern Switzerland 1.1. Medical Oncology Service Prof. Michele Ghielmini MD Medical Director

Immuno-Oncology Biomarkers: Progress Update...Immuno-Oncology Biomarkers: Progress Update Josep M. Piulats, MD, PhD Department of Medical Oncology, Institut Català d’Oncologia–IDIBELL,

Immuno-oncology Translational Research Initiative Planning ... · Immuno-oncology Translational Research Initiative Planning Workshop Report Thursday, November 26, ... OICR (e.g.,

Structured Immuno-Oncology Combination Strategies To ... · Structured Immuno-Oncology Combination Strategies To Maximize Efficacy Jun Wang MD, PhD Senior Medical Director Immunotherapy